This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2016 Nov 5;388(10057):2237.

doi: 10.1016/S0140-6736(16)32074-8.

Lessons from the controversy over statins

Virginia Barbour¹

Affiliations

PMID: 27825504
DOI: 10.1016/S0140-6736(16)32074-8

Comment

Lessons from the controversy over statins

Virginia Barbour. Lancet. 2016.

. 2016 Nov 5;388(10057):2237.

doi: 10.1016/S0140-6736(16)32074-8.

Author

Virginia Barbour¹

Affiliation

¹ Committee on Publication Ethics, Brisbane, QLD 4000, Australia. Electronic address: cope_chair@publicationethics.org.

PMID: 27825504
DOI: 10.1016/S0140-6736(16)32074-8

No abstract available

PubMed Disclaimer

Comment in

Lessons from the controversy over statins - Editor's reply.
Horton R. Horton R. Lancet. 2016 Nov 5;388(10057):2237. doi: 10.1016/S0140-6736(16)32082-7. Lancet. 2016. PMID: 27825505 No abstract available.
Lessons from the controversy over statins - Authors' reply.
Armitage J, Baigent C, Collins R. Armitage J, et al. Lancet. 2016 Nov 5;388(10057):2237-2238. doi: 10.1016/S0140-6736(16)32075-X. Lancet. 2016. PMID: 27825506 No abstract available.

Comment on

Offline: Lessons from the controversy over statins.
Horton R. Horton R. Lancet. 2016 Sep 10;388(10049):1040. doi: 10.1016/S0140-6736(16)31583-5. Lancet. 2016. PMID: 27628511 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information